Conversely, the highly invasive, fibroblast-like MDA-MB-231 line was derived from a metastatic carcinoma and is not hormone sensitive as it is a TNBC, lacking estrogen receptor, PR and human epidermal growth factor receptor 2 (HER2) expression. Here, ERBB2 is linked to metastatic carcinoma.